Andrzej Januszewicz studied medicine at Warsaw Medical University where he received his MD in 1981 and between 1981 and 1982 he completed his internship. Between 1981-1982 and 1984-1985 Andrzej Januszewicz was a Visiting Fellow at the Department of Hypertension, Cornell University Medical Center, New York, USA (Head: prof J.Laragh) and at the Department of Hypertension, Ochsner Medical Foundation, New Orleans, USA (Head: prof E. Frohlich) , respectively. In 1986 Andrzej Januszewicz began to work at the Department of Hypertension and Internal Medicine , Warsaw, Poland (Head: prof. W. Januszewicz) remaining at Warsaw Medical University until 1998. In 1986 he received his doctoral degree , in 1993 Andrzej Januszewicz was appointed associate professor in medicine and in 1998 he was nominated professor of medicine by the President of Polish Republic. From 1998 until now Andrzej Januszewicz is working at the National Institute of Cardiology and since 2000 until now he is a Head of Department of Hypertension. Between 2008-2017 he was a Chairman of the Scientific Council of the National Institute of Cardiology and since 2017 until now he is a Vice-Chairman of the Scientific Council. From 2010 Andrzej Januszewicz is a member of Polish Academy of Sciences. Between 2004-2006 he was a President of the Polish Society of Hypertension and currently he is a Council member of the Society. From 2017 Andrzej Januszewicz is a member of the Council of the European Society of Hypertension and from 2019 until now he is a Secretary of the European Society of Hypertension. His main research topics in the field of hypertension were the role of atrial natriuretic hormone , endothelin-1 and renin-angiotensin-aldosterone in the pathogenesis of essential hypertension. As a visiting fellow at Cornell University he was working in the research team who as one of the first in the world presented the structure and biologic activities of atrial natriuretic hormone (Nature, 1985}. Current research of Andrzej Januszewicz relates to the clinical aspects of renovascular hypertension, pheochromocytoma-paraganglioma and primary aldosteronism. Other areas of interest are obstructive sleep apnoea, resistant hypertension and interventional treatment of difficult to treat and resistant hypertension. Current particular interest is on clinical and molecular aspect of fibromuscular dysplasia. Andrzej Januszewicz has a wide experience in clinical research, including membership of steering committees of several international trials in hypertension, diabetes and lipid disorders that have been important for clinical practice. Andrzej Januszewicz publications include over 500 articles , book chapters and books and he has published 260 original scientific articles and review articles in the leading journals including Nature, Nature Genetics, New England Journal of Medicine , Lancet, Hypertension, Journal of Hypertension, Cardiovascular Research , American Journal of Human Genetics, JACC Imaging , JAMA and Kidney International. He has H-index of 42, Impact Factor of 840 and his work has been cited over 14,000 times. Andrzej Januszewicz awards and distinctions include Award of the Ministry of Health (1998) , The Blood Pressure 10th Anniversary Research Prize (2002) , Award of the Polish Academy of Arts and Sciences (Cracov) ( 2002) , Award of the Prime Ministry of Poland (2002), Award MISTRZ of the Polish Foundation of Sciences (2008) , Foundation Kościuszko Award (2017) and Gloria Medicinae Medal (2020).